SDC1 and Miyoshi myopathy: Matsui et al. [16] found that CD138− cells from both human MM cell lines and primary patient samples had greater clonogenic potential both in vitro and in non obese diabetic/severe combined immunodeficiency (NOD/SCID) mice, compared to corresponding CD138+ plasma cells.